SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on September 13, 2021. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut, and its common stock trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes and Events
Under Item 7.01 (Regulation FD Disclosure), the Company announced its intention to install a PURE EP™ System at St. Elizabeth’s Medical Center in Boston, MA. This represents a new business development and potential revenue opportunity rather than a change in historical financial performance.
Guidance, Outlook, and Risks
The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials regarding the installation announcement. The filing includes standard disclaimers that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not intended to constitute a determination of materiality under Regulation FD.
Investor Verification Checklist
- Verify the status of the PURE EP™ System installation at St. Elizabeth’s Medical Center.
- Confirm if this installation results in a signed contract or revenue recognition in future periods.
- Review the attached Exhibit 99.1 (Press Release) for additional details on the scope of the project.
- Check subsequent filings for updates on the installation timeline or any changes to the agreement.